健康

Search documents
世界人工智能大会第3天,医疗大健康重磅论坛亮相!
第一财经· 2025-07-15 08:06
文 /盼达 AI,"第五次工业革命"的主引擎,当前各领域技术创新的核心驱动力; 医疗健康,个人幸福与社会稳定和谐的基石; 以下文章来源于健闻咨询 ,作者健闻商业 健闻咨询 . 医疗行业跨界洞察 可持续发展,联合国提出的全球发展目标(今年刚好是目标提出的第十年),当代社会经济发展的核心 理念。 AI+医疗健康+可持续发展,将会碰撞出怎样的火花? 7月28日,2025世界人工智能大会第三天,由大会战略合作媒体第一财经与旗下医疗健康官方账号健闻 咨询联合举办的"AI+医健产业可持续创新论坛",将于当天下午在上海市浦东新区世博中心518会议厅举 行。 "AI+医健产业可持续创新论坛"将在AI蓬勃发展,赋能新质生产力的背景之下,探讨中国医疗大健康产 业的可持续创新发展。论坛将邀请相关政府部门、行业协会及研究机构的代表,一线内外资医疗健康企 业及互联网医疗企业的高管,医疗健康投 资和咨询机构高管,高校智库专家学者等共同参会。 本次论坛将重磅发布《2025医健可持续创新案例推荐榜》。 《推荐榜》由第一财经、健闻咨询和上海 现代服务业联合会医疗服务专业委员会共同发起,邀约多方专家,设立"医健可持续创新案例提名委员 会",经过 ...
苏州盛会见证健颐项目:水火“并”济,开启健康生活全新时代
Zhong Guo Shi Pin Wang· 2025-07-15 05:50
在当下健康意识愈发深入人心的时代背景下,一场聚焦健康饮水领域的盛会于2025年7月13日在苏州盛大举行——健颐项目新品发布会重磅开启。此次发布 会以"水火'并'济,开启健康新生活"为主题,隆重推出了健颐集团潜心研发的72小时老火水。活动现场星光璀璨,众多行业专家、合作伙伴以及媒体代表齐 聚一堂,共同见证这一具有里程碑意义的创新产品诞生。这一盛会为健康饮水市场注入了全新活力,也预示着一种全新的健康生活方式正加速向我们走来。 健颐集团:创新领航,开启健康生活新征程 健颐集团的宏伟目标不止于此。它正以科技创新为动力,以家族传承为纽带,全力打造一个涵盖老水、老茶、老艾的"大生活"生态圈。在这个生态圈里,饮 食、养生、文化实现了深度融合。 在如今竞争激烈的商业浪潮中,健颐集团宛如一颗耀眼的明星,凭借独特的创新理念,走出了一条与众不同的发展道路。自2008年创立以来,健颐集团便将 目光聚焦于"健康+生活"领域,始终怀揣着把健康理念融入大众日常生活的美好愿景。 此次惊艳亮相的老火水,正是健颐集团多年潜心研发、持续创新的成果结晶。它并非普通的饮用水,更象征着一种全新的健康生活态度。老火水巧妙地将水 与厨房紧密相连,历经72小 ...
城市24小时 | 机场“上新”,沿海大省补齐“最后拼图”
Mei Ri Jing Ji Xin Wen· 2025-07-14 16:24
每经记者|杨欢 每经编辑|刘艳美 据浙江发布消息,7月18日丽水机场将迎来首航,标志着丽水正式迈入"航空时代"。丽水机场距市中心约15公里,定位为国内 支线机场、旅游机场,飞行区等级为4C,本期按年旅客吞吐量100万人次、货邮吞吐量4000吨的规模设计。航站楼融合丽水山 水特色,集便捷出行与特色商业于一体,为旅客提供安全、便捷、舒适的乘机体验。 丽水机场初期将开通北京首都、上海浦东航线,8月起,将陆续开通深圳、贵阳、广州航线(具体执飞航司及时刻待民航批复 后公布)。10月民航冬春换季后,计划进一步增加前往重庆、成都、西安、长沙、武汉、青岛、哈尔滨等热门城市的航线 (将根据保障能力稳步推进)。 解读:浙江省发展规划研究院课题组曾在2023年提出过一条浙江地区差距的分割线——"清大线",以杭州临安清凉峰镇为起 点,到温州苍南大渔镇为终点的直线。线的东北侧,水系纵横、土壤肥沃,经济社会发展总体较好;线的西南侧,群山连 绵、耕地稀缺,经济发展水平相对落后。 从地图上看,丽水基本位于"清大线"西南侧,市域面积1.73万平方公里,是浙江省陆域面积最大的地级市,占全省的1/6,全市 90%以上的辖区面积是山地,素有"九山半 ...
百龙创园(605016):阿洛酮糖正式上市,产品结构持续优化,业绩稳健增长
Shenwan Hongyuan Securities· 2025-07-14 15:23
Investment Rating - The report maintains an "Outperform" rating for the company [2] Core Insights - The company achieved a revenue of 650 million yuan in H1 2025, representing a year-on-year increase of 22%, with a net profit of 171 million yuan, up 43% year-on-year [7] - The official launch of allulose marks a significant milestone, with expectations for increased sales in 2025 due to its unique properties and regulatory approvals in multiple countries [7] - The successful transformation towards high-end dietary fiber products is expected to enhance profitability, driven by the production of resistant dextrin [7] - Ongoing construction of a facility in Thailand aims to capitalize on the synthetic biology trend, further upgrading the company's product offerings [7] - The company is projected to achieve net profits of 365 million, 473 million, and 593 million yuan for 2025, 2026, and 2027 respectively, with corresponding EPS of 0.87, 1.13, and 1.41 yuan per share [7] Financial Data and Profit Forecast - Total revenue is forecasted to reach 1,716 million yuan in 2025, with a year-on-year growth rate of 49% [6] - The gross profit margin is expected to be 34% in 2025, with a return on equity (ROE) of 17.9% [6] - The company’s earnings per share (EPS) is projected to be 0.87 yuan in 2025, with a price-to-earnings (PE) ratio of 26 [6]
据港交所文件:上海镁信健康科技集团股份有限公司向港交所提交上市申请书。
news flash· 2025-07-14 14:54
据港交所文件:上海镁信健康科技集团股份有限公司向港交所提交上市申请书。 ...
增配中国!200万亿全球主权投资机构重磅调查
Zhong Guo Ji Jin Bao· 2025-07-14 13:55
Core Insights - Sovereign investment institutions are significantly increasing their interest in the Chinese market, with 59% of respondents planning to allocate more resources to China over the next five years [1][6] - The report highlights China's leadership in technology innovation and its role as a leader in the green transition, particularly in clean energy and green technology [1][8] Group 1: Investment Trends - 73% of North American sovereign wealth funds believe they will increase their allocation to China in the next five years, while 88% of Asia-Pacific sovereign wealth funds share this sentiment [2][6] - The focus is shifting towards innovation-driven sectors in China, which are expected to establish global leadership positions [5][11] - Sovereign wealth funds are increasingly viewing China as a global leader in sectors such as semiconductors, cloud computing, artificial intelligence, electric vehicles, and renewable energy infrastructure [7][8] Group 2: Sector Preferences - When asked about the most attractive industries in China over the next 3-5 years, 89% of sovereign wealth funds mentioned digital technology and software, 70% cited advanced manufacturing and automation, and 70% highlighted clean energy and green technology [11] - 48% of respondents identified healthcare and biotechnology as attractive sectors, indicating a broad interest in various high-growth industries [11] Group 3: Central Bank Insights - 64% of central banks plan to increase their gold reserves in the next two years, reflecting a strategic shift in reserve management amid geopolitical instability [13] - 47% of central banks expect to increase gold allocation over the next three years, viewing gold as a strategic hedge against rising U.S. debt levels and global fragmentation [13]
科技重塑睡眠:可穿戴设备、AI与数字化疗法驱动的睡眠健康创新报告,头豹词条报告系列
Tou Bao Yan Jiu Yuan· 2025-07-14 12:09
年 睡眠健康行业词条报告 头豹分类/卫生和社会工作/卫生/其他卫生活动/其他 Copyright © 2025 头豹 科技重塑睡眠:可穿戴设备、AI与数字化疗法驱动的睡眠健康创新报 告 头豹词条报告系列 何婉怡 · 头豹分析师 2025-06-24 未经平台授权,禁止转载 行业分类: 卫生和社会工作/其他 摘要 睡眠健康行业致力于改善和维护个体睡眠质量,满足消费者对优质睡眠的追求。随着睡眠问题日益严峻,政策持续优化,消费者注重效果与安全,对智能化、个性化产品接 受度高。行业规模持续扩大,科技创新推动从单一产品制造向智能化解决方案转变。未来,消费者对睡眠质量的重视、科技的深度融入、防病理念的普及、银发经济的崛起 以及线上线下融合的销售模式,将进一步推动睡眠健康行业市场规模的攀升。 睡眠是人类维持生命的基本需求,对维系身心健康至关重要。睡眠健康行业是指围绕改善和维护个体睡眠质量、预防和治疗睡眠障碍,以及 提升睡眠相关健康水平而开展的一系列商业活动和专业服务的统称。该行业致力于通过多维度、跨领域的手段和产品,满足消费者对优质睡眠的 追求,缓解因睡眠问题引发的生理、心理和情绪困扰,进而对社会经济、医疗保健以及消费者的 ...
总规模破千亿!江苏省战新母基金又有新动作
Zheng Quan Shi Bao Wang· 2025-07-14 12:05
江苏省战略性新兴产业母基金(简称"江苏省战新母基金")第三批产业专项基金正式启动。 截至目前,江苏战新基金集群已经实现全省13个设区市全覆盖,重点投资新能源、新能源(智能网联)汽 车、低空经济和空天产业、新型电力(智能电网)、海工装备与高技术船舶、新材料等产业领域。 此外,江苏省农垦集团发起的规模10亿元的江苏农垦现代生物技术产业投资基金,将围绕医药健康、生 物农业、特色新型食品等相关领域开展直投,进一步加大省属企业战略性新兴产业投资布局,增强国有 企业核心功能、提高核心竞争力。 在扶持天使投资方面,由江苏高投集团和苏州创新投资集团共同发起的5亿元江苏省新智未来产业天使 投资基金,重在支持更多高层次人才创新创业,推动通用智能、先进计算、第三代半导体、量子科技、 合成生物、前沿新材料、深海、深地、空天开发等未来产业领域更多前沿科技成果转化落地,进一步服 务江苏省打造具有全球影响力的产业科技创新中心。 据悉,江苏省战新母基金自去年6月正式启动运作至今刚满一年,该基金充分发挥政府引导基金的撬动 效应,成效显著,有力支撑了全省战略性新兴产业和未来产业的发展壮大:目前两批产业专项基金共36 只、规模914亿元已全部组建 ...
微生态健康食品开创品牌“轻又清”获得多方战略投资
Sou Hu Cai Jing· 2025-07-14 07:21
7月11日,"产研融合加速 赋能肠道健康"中加益生元产研融合战略合作发布会上在北京举行,微生态健康食品开创品牌"轻又清"获得加拿大主板上市公司 BioNeutra(TSX.V:BGA)与惠买集团战略投资,估值数千万。 此次产研融合战略合作由"轻又清"发起,BioNeutra、惠买集团及青岛农业大学共同推动,助力中国益生元产业进入国际化产学研创新发展新阶段。北京协 和医院营养科主任马方、中科院微生物所研究员朱宝利、加拿大主板上市公司BioNeutra总裁朱建华、惠买集团董事长杜瑞勇、"轻又清"品牌创始人陈晓 强、青岛农业大学菊粉专项课题组代表秦洋、深创投北京公司总经理刘纲、和伙人平台董事长邱朝敏等重量级嘉宾出席此次发布会并致辞。 肠道健康问题已经成为不可忽视的隐患 随着社会经济的快速发展,老百姓的生活水平不断提高,大鱼大肉已成为餐桌上的家常便饭,而随之带来的高脂肪、膳食纤维长期摄入不足等营养不均衡问 题引发肠道健康问题,已经成为不可忽视的隐患。北京协和医院营养科主任马方表示,"菊粉是一种天然膳食纤维,也是一种优质益生元,是肠道益生菌的 营养素。经常补充益生元对肠道功能的恢复、肠道状态的稳定非常有帮助,我们在多年 ...
实测爸妈着迷的AI问诊:竟用广告证明曾被罚“特效药”疗效
Nan Fang Du Shi Bao· 2025-07-14 07:16
Core Viewpoint - The increasing use of AI health assistants among the elderly raises concerns about their ability to effectively filter misleading health information and provide reliable guidance, especially regarding "miracle drugs" and health rumors [2][3][13]. Group 1: AI Health Assistants Evaluation - A recent evaluation by Southern Metropolis Daily and Nandu Big Data Research Institute assessed 10 AI health assistants, including 5 general models and 5 specialized models, focusing on their ability to identify and correct health rumors [2][3]. - The tested AI health assistants generally performed well in recognizing health rumors and providing chronic disease management advice, but some failed to identify the exaggerated claims of "miracle drugs" [2][9]. - Specific models, such as Tongyi Qianwen and Quark Health Manager, incorrectly classified certain products as having scientific support for their efficacy, highlighting a reliance on promotional content rather than objective analysis [9][10]. Group 2: Misleading Health Claims - The evaluation identified several controversial products, such as "Can South Star Oral Liquid" and "Acid Friend Probiotic," which have been previously flagged for false advertising [3][4]. - Many AI models based their responses on promotional materials rather than authoritative sources, leading to potentially misleading conclusions about the efficacy of these products [10][12]. - The majority of AI health assistants were found to reference promotional content without consulting more credible sources or expert opinions, raising concerns about the reliability of their guidance [9][10]. Group 3: Rumor Correction and Chronic Disease Management - Despite shortcomings in identifying "miracle drugs," the AI health assistants demonstrated a high ability to recognize and correct common health rumors, using authoritative sources for analysis [13][14]. - The evaluation included specific inquiries about symptoms related to chronic diseases, where AI models provided structured guidance and recommendations based on the nature and risks of conditions like vascular plaque [14][15]. - Some specialized models offered additional services, such as connecting users to online consultations with doctors, enhancing the depth of their health management capabilities [14][15].